N@N

Celldex to Report Fourth Quarter and Fiscal 2008 Financial Results on February 27, 2009

_{//health-fitness.news-articles.net/content/2009/ .. -2008-financial-results-on-february-27-2009.html}
^{Published in Health and Fitness on Monday, February 23rd 2009 at 13:06 GMT, Last Modified on 2009-02-23 13:07:01 by Market Wire}  

NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (Nasdaq: CLDX) will release its fourth quarter and fiscal 2008 financial results before U.S. financial markets open on Friday, February 27, 2009.

Celldex executives will host a conference call and live audio webcast at 9:00 am ET that same day. To access the live call, dial 888-713-4213 (within the United States) or 617-213-4865 (outside the United States). The passcode for participants is 46614188. A replay will be available approximately two hours after the live call. To access the replay, dial 888-286-8010 (within the United States) or 617-801-6888 (outside the United States). The passcode I.D. # is 52405186. The replay will also be broadcast via the company's website [ www.celldextherapeutics.com ] approximately two hours after the live call.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].